Insider Trading Alert - VEEV, LB And ANF Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Friday, June 5, 2015, 80 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $368.50 to $15,580,000.00.

Highlighted Stocks Traded by Insiders:

Veeva Systems (VEEV) - FREE Research Report

Faddis Jonathan, who is VP, General Counsel, Secretary at Veeva Systems, sold 177 shares at $27.56 on June 5, 2015. Following this transaction, the VP, General Counsel, Secretary owned 323 shares meaning that the stake was reduced by 35.4% with the 177-share transaction.

Zuppas Eleni Nitsa, who is Chief Marketing Officer at Veeva Systems, sold 737 shares at $27.07 on June 5, 2015. Following this transaction, the Chief Marketing Officer owned 2,604 shares meaning that the stake was reduced by 22.06% with the 737-share transaction.

The shares most recently traded at $27.45, up $0.38, or 1.38% since the insider transaction.

The average volume for Veeva Systems has been 1.1 million shares per day over the past 30 days. Veeva Systems has a market cap of $2.0 billion and is part of the technology sector and computer software & services industry. Shares are up 4.58% year-to-date as of the close of trading on Friday.

Veeva Systems Inc. provides cloud-based software solutions for the life sciences industry in North America, Europe, the Asia Pacific, and Latin America. The company has a P/E ratio of 83.2. Currently, there are 8 analysts who rate Veeva Systems a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on VEEV - FREE

TheStreet Quant Ratings rates Veeva Systems as a sell. Among the areas we feel are negative, one of the most important has been premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full Veeva Systems Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

L Brands (LB) - FREE Research Report

Coe Nicholas, who is CEO-Bath and Body Works at L Brands, sold 15,000 shares at $87.11 on June 5, 2015. Following this transaction, the CEO-Bath and Body Works owned 23,587 shares meaning that the stake was reduced by 38.87% with the 15,000-share transaction.

The shares most recently traded at $85.26, down $1.85, or 2.17% since the insider transaction. Historical insider transactions for L Brands go as follows:

  • 4-Week # shares sold: 12,404
  • 12-Week # shares sold: 43,154
  • 24-Week # shares sold: 43,154

The average volume for L Brands has been 1.4 million shares per day over the past 30 days. L Brands has a market cap of $25.5 billion and is part of the services sector and retail industry. Shares are down 1.26% year-to-date as of the close of trading on Friday.

L Brands, Inc. operates as a specialty retailer of women's intimate and other apparel, beauty and personal care products, and accessories. The company operates in three segments: Victoria's Secret, Bath & Body Works, and Victoria's Secret and Bath & Body Works International. The stock currently has a dividend yield of 2.29%. The company has a P/E ratio of 24.4. Currently, there are 13 analysts who rate L Brands a buy, no analysts rate it a sell, and 15 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on LB - FREE

TheStreet Quant Ratings rates L Brands as a buy. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, revenue growth, solid stock price performance and expanding profit margins. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full L Brands Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Abercrombie & Fitch (ANF) - FREE Research Report

Horowitz Bonadies Fran, who is President of Hollister brand at Abercrombie & Fitch, bought 10,000 shares at $22.55 on June 5, 2015. Following this transaction, the President of Hollister brand owned 10,000 shares meaning that the stake was boosted by 100% with the 10,000-share transaction.

The shares most recently traded at $22.58, up $0.03, or 0.13% since the insider transaction. Historical insider transactions for Abercrombie & Fitch go as follows:

  • 4-Week # shares bought: 2,800
  • 4-Week # shares sold: 2,000
  • 12-Week # shares bought: 15,000
  • 12-Week # shares sold: 2,000
  • 24-Week # shares bought: 35,000
  • 24-Week # shares sold: 2,000

The average volume for Abercrombie & Fitch has been 2.7 million shares per day over the past 30 days. Abercrombie & Fitch has a market cap of $1.6 billion and is part of the services sector and retail industry. Shares are down 21.61% year-to-date as of the close of trading on Friday.

Abercrombie & Fitch Co., through its subsidiaries, operates as a specialty retailer of apparel for men, women, and kids. The company operates through three segments: U.S. Stores, International Stores, and Direct-to-Consumer. The stock currently has a dividend yield of 3.48%. The company has a P/E ratio of 37.7. Currently, there are 6 analysts who rate Abercrombie & Fitch a buy, 5 analysts rate it a sell, and 13 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ANF - FREE

TheStreet Quant Ratings rates Abercrombie & Fitch as a hold. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, deteriorating net income and disappointing return on equity. Get the full Abercrombie & Fitch Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you liked this article you might like

10 Favorite Healthcare Stocks for 2018: Medical Marijuana to Opioid Treatment

10 Favorite Healthcare Stocks for 2018: Medical Marijuana to Opioid Treatment

GLD Trade Has Lost Its Shine

GLD Trade Has Lost Its Shine

Viva La Veeva Volatility

Viva La Veeva Volatility

'Cloud Wars' Intensify; Staples Shows Some Staying Power -- ICYMI Friday

'Cloud Wars' Intensify; Staples Shows Some Staying Power -- ICYMI Friday

Cloud Software Is Booming -- Just Ask Workday and Salesforce

Cloud Software Is Booming -- Just Ask Workday and Salesforce